Company facts for investors, buyers, job seekers, and healthcare professionals
Find healthcare AI companies that fit the work you need done. Compare their products and ownership, then follow company news and evidence before deciding what to explore next.
Know What the Company Is, What Changed, and Where to Verify It
Each profile connects the company to its market category, ownership, stock name or public parent, careers, qualification signals, first-hand developments, evidence, and FDA records.
Commure said on 20 October 2026 that Commure Autonomous Coding had achieved Epic Toolbox designation for fully autonomous coding. The announcement describes the Toolbox designation as marking vendors that follow Epic's recommended Blueprint and integration practices, which it says streamlines integration and security review and lets coders check codes inside their existing Epic system. Commure says the product recommends ICD-10, CPT and E&M codes and modifiers with a written rationale, covering the step from a clinician's note through claim creation. The announcement reports that at Ob Hospitalist Group, described as the nation's largest OB/GYN provider group, clinicians cut charge entry time by 83 percent within three months and the software coded more than 85 percent of all charges. Tanay Tandon, Commure's chief executive, is quoted saying healthcare spends more than 250 billion dollars a year on administrative work that produces no clinical value.
Why it matters: Toolbox designation is an integration and process credential, not a measure of coding accuracy. It matters because it removes a real obstacle: coders reviewing AI output in a second application is where a lot of autonomous coding pilots quietly die. The customer figures are the part worth pressing on. An 83 percent cut in charge entry time is a measure of clinician effort, and 85 percent of charges coded is a measure of how much work the software took on, but neither one tells you whether the codes were right or whether denials went up or down. A revenue cycle leader should ask for the accuracy and denial numbers beside these two before treating the result as a win, and should note that an obstetrics hospitalist group has a narrower range of cases than a general hospital.
Philips said on 14 October 2026 that it had reached 1,000 global installations of SmartSpeed Precise, its AI-based MRI image reconstruction software. The company says the software is used in at least 95 percent of compatible clinical scanning on the systems where it is installed. Its stated performance claims are that SmartSpeed Precise delivers images up to 80 percent sharper and lets scans be completed up to three times faster compared with Philips SENSE imaging, that it can save an average of 215 hours of scanning time per system per year, and that this represents capacity for roughly 624 additional MRI examinations per system each year, or about 215,000 hours and more than 624,000 additional examinations across all 1,000 systems. Ioannis Panagiotelis, business leader for MRI at Philips, is quoted saying faster is only meaningful when it comes with the image quality clinicians need.
Why it matters: The adoption figure is the useful part of this announcement. Plenty of imaging AI gets bought, installed and then left switched off because it slows the technologist down or the radiologists do not trust the output, so a vendor claiming the software runs on nearly every eligible scan is making a claim it can be checked on. The time figures need more care. The 215 hours and the 624 extra examinations are Philips arithmetic built on its own comparison against its older SENSE method, not an independent measurement, and extra scanner capacity only turns into extra examinations if a department also has the staff and the referrals to fill it. Nothing here is a clinical claim, and faster scans with sharper pictures do not by themselves mean a better diagnosis.
Abridge said on 13 October 2026 that Abridge Assistant, which works inside the records system and is reached by chat or by voice, is now available to every clinician at every health system it serves, following a release in September. The company says the assistant pulls relevant details out of the chart with the sources cited, surfaces clinical guidance, drafts documents such as referrals and handoffs for a clinician to review, personalises notes using the patient's context, and can fold a health system's own clinical pathways into its answers. Abridge says it shows its work step by step rather than returning an answer alone, and that more than 300 enterprise health systems use its products. Abridge says it works with Epic and other records systems. Matt Troup, a physician assistant and Abridge clinical strategy principal, is quoted saying the assistant knows his patient and shows the work.
Why it matters: Drafting a note from a conversation that already happened is a contained job. Answering a question about a patient, and offering guidance, is not, because a wrong answer can reach a decision. Two things in the announcement are the ones to hold onto. The citations and the visible reasoning steps are the part an informatics team can actually audit, so ask whether a clinician can click through to the chart entry behind every claim. And the clinical pathway feature means the answers will reflect whichever version of the pathway was loaded, which makes pathway governance a safety job rather than a content job. Nothing here is a clinical claim, and Abridge describes the drafts as material for a clinician to review, not to send.
DeepScribe said on 13 October 2026 that Comprehensive Cancer Centers of Nevada had made its ambient AI part of care across 13 treatment locations in Southern Nevada, covering 59 oncology clinicians. The announcement reports over 90 percent clinician adoption, says 80 percent of all patient encounters are documented using the platform, and says 8 in 10 clinicians were using its SmartPrep pre-visit feature by the second month. It says the rollout runs on the practice's iKnowMed records system, and describes the practice as participating in more than 150 clinical trials a year and having contributed to the development of more than 100 therapies approved by the FDA. Rupesh Parikh, the practice president, is quoted saying DeepScribe has given its physicians room back. Matthew Ko, DeepScribe's chief executive and founder, is quoted saying the speed of adoption signals the company is helping solve the right problems. The announcement gives no time-saved figure.
Why it matters: This is the first brief this site holds for DeepScribe, and the useful thing about it is what it measures. Ambient documentation tools are usually sold on minutes saved, a number that is hard to verify and easy to inflate. Adoption and share of encounters documented are harder to fake, because a clinician who dislikes the tool simply stops opening it. Treat the setting as the main caveat: oncology visits in a single practice follow familiar patterns, with the same clinicians and the same record system, which is a much easier environment than a general hospital with rotating staff. Note also that the location and clinician counts come from the vendor, and the practice's own pages describe 12 treatment centres and over 600 medical professionals, so the two organisations are counting different things.
One Company Profile, the Facts Around It
A company name alone does not tell you what you can buy, whether the stock is direct exposure, what jobs require, or which claims hold up. AI Healthcare Now connects those questions so you can move from an announcement to the company, market, evidence, regulation, and career facts behind it.
Some healthcare AI companies have their own listed shares. Others belong to public parents or remain private; this guide separates those relationships.
An AI governance framework for a hospital is not a policy document. It is a standing decision process that says who approves an AI tool, what evidence they require, who owns it after go-live, and what triggers turning it off. Most of what gets published as a framework skips the last two.
There is no AI compliance regime in United States healthcare. There are existing obligations that AI tools fall inside, and the compliance work is figuring out which ones apply to which tool. That reframing removes most of the confusion and all of the waiting.
Responsible AI claims become useful when a hospital can verify who was studied, what the clinician sees, who owns failures, and what gets measured after launch.
Get research notes, vendor category updates, patient discovery trends, and healthcare AI strategy briefings.
Related Properties
AI Healthcare Now connects the healthcare AI conversation to a wider network of specialized healthcare, aging, longevity, and medical marketing properties.
